-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

CASI, Cleave Say China Drug Regulator Approves Clinical Trial Application for CB-5339 in Patients With Multiple Myeloma

CASI, Cleave Say China Drug Regulator Approves Clinical Trial Application for CB-5339 in Patients With Multiple Myeloma

MT Newswires · 01/06/2023 05:26